Table 5.

Patient demographics, histological diagnosis, location of tumor, blood loss, transfusion requirement and surgical time of study group and control group for the giant cell tumors of extremities

S.No	Study group (embolisation group), n = 18							Control group (non-embolisation group), n = 22
	Age/sex	Diagnosis	Site	Embolising agent	Blood loss (mL)	Transfusion (mL)	Surgical time (min)	Age /sex	Diagnosis	Site	Blood loss (mL)	Transfusion (mL)	Surgical time (min)
1	52 M	GCT	LL	PVA + GEL FOAM	2900	1400	230	46 F	GCT	LL	1300	1400	240
2	30 M	GCT	LL	PVA + GEL FOAM	1740	700	231	58 M	GCT	LL	1600	1450	230
3	42 M	GCT	LL	PVA + GEL FOAM	1500	700	340	31 M	GCT	LL	1250	1050	220
4	39 F	GCT	LL	PVA + GEL FOAM	1600	700	240	21 M	GCT	LL	2500	1050	145
5	45 F	GCT	LL	PVA + GEL FOAM	1300	350	180	34 F	GCT	LL	1800	1400	150
6	31 M	GCT	LL	PVA	250	0	115	60 F	GCT	LL	1200	700	150
7	20 F	GCT	UL	PVA + GEL FOAM	1300	700	250	20 M	GCT	LL	6000	8400	450
8	15 M	GCT	UL	PVA + GEL FOAM	500	350	170	30 M	GCT	LL	2000	2100	350
9	32F	GCT	LL	PVA + GEL FOAM	1600	700	260	45F	GCT	LL	1500	1400	225
10	30 F	GCT	UL	PVA	350	0	135	22 M	GCT	LL	4300	2100	315
11	28 F	GCT	LL	PVA + GEL FOAM	1400	700	240	40 F	GCT	LL	1800	1400	245
12	32 M	GCT	LL	PVA	400	350	190	24 F	GCT	LL	800	700	290
13	45 F	GCT	UL	PVA	2100	1050	245	17 M	GCT	UL	1800	700	180
14	20 M	GCT	LL	PVA	600	0	125	22 F	GCT	LL	1500	1050	260
15	20 F	GCT	LL	PVA	800	350	145	34 M	GCT	UL	900	700	245
16	82 M	GCT	LL	PVA	900	350	155	29 F	GCT	LL	1500	1400	270
17	22 M	GCT	UL	PVA + GEL FOAM	1800	1400	230	26 M	GCT	LL	1600	1050	290
18	42 F	GCT	UL	PVA	300	0	140	27 F	GCT	LL	2600	2100	335
19								18 M	GCT	LL	3450	2450	330
20								23 F	GCT	UL	2600	2050	285
21								21 F	GCT	LL	2100	1400	245
22								24M	GCT	LL	1900	1400	290

GCT: Giant cell tumor; UL: Upper limb; LL: Lower Limb; PVA: Polyvinyl alcohol.